MOLECULAR PARTNERS SF 1MOLECULAR PARTNERS SF 1MOLECULAR PARTNERS SF 1

MOLECULAR PARTNERS SF 1

No trades
See on Supercharts

Price target

9.010.000.00%
The 6 analysts offering 1 year price forecasts for 6ML have a max estimate of — and a min estimate of —.

Analyst rating

Based on 6 analysts giving stock ratings to 6ML in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


6ML EPS for the last quarter is −0.47 EUR despite the estimation of −0.38 EUR. In the next quarter EPS is expected to reach −0.44 EUR. Track more of MOLECULAR PARTNERS SF 1 financials and stay on top of what is up with the company.
In the next quarter MOLECULAR PARTNERS SF 1 revenue is expected to reach 0.00 EUR. Check out MOLECULAR PARTNERS SF 1 revenue and earnings and make informed decisions.
According to analysts, 6ML price target is 9.01 EUR with a max estimate of 15.90 EUR and a min estimate of 6.36 EUR. Check if this forecast comes true in a year, meanwhile watch MOLECULAR PARTNERS SF 1 stock price chart and keep track of the current situation with 6ML news and stock market news.
We've gathered opinions of 6 analysts rating 6ML stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.